Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature.
Mariño-Enríquez A, González-Rocha T, Burgos E, Stolnicu S, Mendiola M, Nogales FF, Hardisson D.
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R.
Pathology. 2021 Feb;53(2):141-156. doi: 10.1016/j.pathol.2020.10.007. Epub 2020 Dec 30.
PMID:33388161
Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.
Wang Y, Zhang Y, Wang F, Li T, Song X, Shi H, Du J, Zhang H, Jing H, Han J, Tong D, Zhang J.
Sci Rep. 2022 Nov 2;12(1):18518. doi: 10.1038/s41598-022-21328-8.
PMID:36323715
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ, Shih IeM.
Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
PMID:20154587
Precursor Lesions of Cervical Clear Cell Carcinoma: Evidence For Origin From Tubo-Endometrial Metaplasia.
Talia KL, Arora R, McCluggage WG.
Int J Gynecol Pathol. 2022 Mar 1;41(2):105-112. doi: 10.1097/PGP.0000000000000785.
PMID:33770055
Primary Transitional Cell Carcinoma of the Endometrium: A Case Report and Review of Literature.
Amjad R, Mogharbel H.
Cureus. 2022 Jan 18;14(1):e21365. doi: 10.7759/cureus.21365. eCollection 2022 Jan.
PMID:35198279
Transitional cell carcinoma of endometrium: a case report of rare pure form.
Cuccia F, Mortellaro G, Spera A, Evangelista G, Lo Casto A, Ferrera G.